Life Sciences Tools and Services
Company Overview of Appistry Inc.
Appistry Inc. develops bioinformatics tools, cloud services, and software solutions that enable healthcare institutions to practice genomically enhanced medicine. Its tools streamline the analysis of data and make genomics data easier to clinical laboratories, research institutions, and hospital practices to act on. The company also provides Appistry CloudDx, a cloud-based system that help institutions conduct patient-centered translational research and hospitals to implement genome-scale tests based on next-generation sequencing (NGS) into routine patient care, as well as helps institutions deliver genomic tests. In addition, it offers CloudDx Translational, a cloud-based solution that cent...
1141 South 7th Street
St. Louis, MO 63104
Founded in 2001
Key Executives for Appistry Inc.
Chairman, Chief Executive Officer and President
Co-Founder, Chief Architect and Vice President of Engineering
Compensation as of Fiscal Year 2017.
Appistry Inc. Key Developments
Appistry Extends Solutions for Next-Generation Sequencing Data Analysis
Aug 11 16
Appistry announced extensions to their product line of genomics software solutions. Firstly the upcoming release of GenomePilot 4.0 will incorporate the capability to perform differential expression analysis of RNA-Seq data. GenomePilot 4.0 focuses on providing an easier way for customers to analyze RNA-Seq data by enabling differential expression analysis in three easy steps: Feature Counts – With a few clicks the user can define a feature count pipeline to identify gene counts for analysis. Experiment Builder – The innovative and intuitive Experiment Builder enables users to easily create an experiment with traits to be analyzed, while GenomePilot auto-populates gene counts into the workflow. Differential Expression – Users can quickly run differential expression analyses and visualize their results within one system without programming or working in multiple tools. Live demonstrations of GenomePilot 4.0 will be held in Appistry booth #40 at the upcoming Next Generation Dx Summit in Washington D.C.August 23-26 with customer availability on September 15, 2016. Secondly, Appistry will begin previewing a new product to the market, GenomeNavigator, which will focus on variant prioritization, clinical interpretation and reporting.
Appistry Enters Partnership with Washington University in St. Louis
May 24 16
Appistry announced that it has entered into a partnership with Washington University in St. Louis. Appistry will integrate the VarScan software, developed at the university’s McDonnell Genome Institute, for variant detection in massively parallel sequencing data with the company’s GenomePilot solution for next-generation sequencing data analysis in the clinical environment. VarScan is available in the current release of GenomePilot.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries